Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Unravelling the role of the immune receptor CD300f in spinal cord injury and metabolic reprogramming

Project description

Elucidating the connection between inflammation and metabolic reprogramming in SCI rehabilitation

Inflammation after spinal cord injury (SCI) affects the progress of both degeneration and regeneration processes. Recent reports suggest that metabolic reprogramming and immune receptors regulate changes in microglia and macrophage phenotypes. The immune receptor CD300f is involved in the phagocytosis of apoptotic cells and synapses, regulates microglia immunometabolic phenotype and displays a unique dual activating/inhibitory function. Funded by the Marie Skłodowska-Curie Actions programme, the CD300f project addresses the interplay between inflammation and metabolic reprogramming, investigating the role of microglia/macrophage CD300f and metabolic reprogramming after SCI. The study also aims to test the efficacy of mitochondrial modulators as a neuroprotective strategy for the stimulation of microglial–mitochondrial oxidative metabolism.

Objective

Inflammation after spinal cord injury (SCI) exerts a key effect on the progress of both degeneration and regeneration after a traumatic injury. In addition, it has become increasingly clear that understanding the interaction between metabolism and immune function can provide an insight into cellular responses to different challenges. Recent reports from our group and others, suggest that metabolic reprogramming and immune receptors play an orchestrated role in modulating microglia and macrophage phenotype. An interesting example is CD300f, a very unique immune receptor that: i) displays a dual activating/inhibitory capacity; ii) is important for the phagocytosis of apoptotic cells and putatively of synapses; and iii) regulates microglia immunometabolic phenotype.
Our hypothesis postulates that, by modulating immunometabolism, CD300f plays an important role in neuroprotection under neuroinflammatory conditions. In the current project, we propose to addresses the interplay between inflammation and metabolic reprogramming by evaluating the role of microglia/macrophage CD300f and their metabolic reprogramming after SCI. We will also test the efficacy of a mitochondrial modulator as a novel neuroprotective strategy for the stimulation of microglial mitochondrial oxidative metabolism.
This proposal is based on a set of unpublished data produced by both the ER at the Institut Pasteur Montevideo and the host institution. We will use novel tools generated by our group as the CD300floxP mice, that crossed with CX3CR1-Creert mice will enable to the conditional CD300f KO in microglia and barrier macrophages, and compare these results with global KO mice. The results generated will provide novel insights related to the mechanisms underlying SCI, and for the understanding of how the immune system and the metabolism dialogue in SCI. This could have important implications in a broad spectrum of neurological diseases, where inflammation contribute detrimentally to the pathology.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-MSCA-IF-2020

See all projects funded under this call

Coordinator

UNIVERSITAT AUTONOMA DE BARCELONA
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 172 932,48
Address
EDIF A CAMPUS DE LA UAB BELLATERRA CERDANYOLA V
08193 Cerdanyola Del Valles
Spain

See on map

Region
Este Cataluña Barcelona
Activity type
Higher or Secondary Education Establishments
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 172 932,48
My booklet 0 0